MCM
MV Capital Management Portfolio holdings
AUM
$972M
1-Year Return
13.49%
This Quarter Return
+0.41%
1 Year Return
+13.49%
3 Year Return
+48.58%
5 Year Return
+71.54%
10 Year Return
+126.45%
AUM
$932M
AUM Growth
-$4.27M
(-0.46%)
Cap. Flow
+$3.47M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
44.61%
Holding
1,102
New
71
Increased
379
Reduced
379
Closed
41
Top Buys
| 1 |
iShares Core MSCI Europe ETF
IEUR
|
+$14.9M |
| 2 |
iShares Russell Mid-Cap ETF
IWR
|
+$2.04M |
| 3 |
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
|
+$1.72M |
| 4 |
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
|
+$1.69M |
| 5 |
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
|
+$1.67M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.88M |
| 2 |
IBDZ
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
|
+$6.52M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$4.95M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
+$2.76M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$2.52M |
Sector Composition
| 1 | Healthcare | 12.12% |
| 2 | Technology | 7.77% |
| 3 | Financials | 4.91% |
| 4 | Consumer Staples | 2.19% |
| 5 | Consumer Discretionary | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
PVH
PVH
$3.93B
| $1.88K | ﹤0.01% |
29
+27
| +1,350% | +$1.75K |
|
702
Five Below
FIVE
$8.05B
| $1.87K | ﹤0.01% |
25
+15
| +150% | +$1.12K |
|
703
Fox Class B
FOX
$23.1B
| $1.85K | ﹤0.01% |
35
| – | – |
|
704
Jacobs Solutions
J
$17.3B
| $1.81K | ﹤0.01% |
15
| – | – |
|
705
Rambus
RMBS
$8.3B
| $1.81K | ﹤0.01% |
35
| – | – |
|
706
DocuSign
DOCU
$15.9B
| $1.79K | ﹤0.01% |
22
+2
| +10% | +$163 |
|
707
Royalty Pharma
RPRX
$15.6B
| $1.78K | ﹤0.01% |
57
+18
| +46% | +$561 |
|
708
MongoDB
MDB
$27.2B
| $1.75K | ﹤0.01% |
10
-6
| -38% | -$1.05K |
|
709
Teladoc Health
TDOC
$1.32B
| $1.72K | ﹤0.01% |
216
-198
| -48% | -$1.58K |
|
710
EPAM Systems
EPAM
$8.53B
| $1.69K | ﹤0.01% |
10
+1
| +11% | +$169 |
|
711
Medical Properties Trust
MPW
$2.77B
| $1.69K | ﹤0.01% |
280
+196
| +233% | +$1.18K |
|
712
Commerce Bancshares
CBSH
$8B
| $1.68K | ﹤0.01% |
27
| – | – |
|
713
10x Genomics
TXG
$1.57B
| $1.68K | ﹤0.01% |
+192
| New | +$1.68K |
|
|
LGF.A
714
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.61K | ﹤0.01% |
182
| – | – |
|
715
Westlake Corp
WLK
$10.9B
| $1.6K | ﹤0.01% |
+16
| New | +$1.6K |
|
716
e.l.f. Beauty
ELF
$7.63B
| $1.57K | ﹤0.01% |
25
+22
| +733% | +$1.38K |
|
717
Hologic
HOLX
$14.6B
| $1.55K | ﹤0.01% |
25
-65
| -72% | -$4.02K |
|
718
CRISPR Therapeutics
CRSP
$4.71B
| $1.53K | ﹤0.01% |
45
+43
| +2,150% | +$1.46K |
|
719
Medpace
MEDP
$13.4B
| $1.52K | ﹤0.01% |
5
+4
| +400% | +$1.22K |
|
720
Atkore
ATKR
$2.04B
| $1.5K | ﹤0.01% |
25
+20
| +400% | +$1.2K |
|
|
CNH
721
CNH Industrial
CNH
$14.1B
| $1.41K | ﹤0.01% |
115
+5
| +5% | +$61 |
|
722
Avantor
AVTR
$8.6B
| $1.41K | ﹤0.01% |
87
-69
| -44% | -$1.12K |
|
723
Doximity
DOCS
$12.9B
| $1.39K | ﹤0.01% |
24
| – | – |
|
724
Novo Nordisk
NVO
$242B
| $1.39K | ﹤0.01% |
20
| – | – |
|
725
Kyndryl
KD
$7.49B
| $1.38K | ﹤0.01% |
44
+1
| +2% | +$31 |
|